Clinical Trial

Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this study is to compare the immunogenicity and safety of sIPV administered via subcutaneous and intramuscular injection routes
Trial Details
NCT Number NCT07457060
Lead Sponsor Sinovac Biotech Co., Ltd
Collaborators: Aga Khan University
Conditions Poliomyelitis
Enrollment 480 participants
Start Date 2025-11-27
Primary Completion 2026-09-08 (estimated)
Study Completion 2026-10-19 (estimated)
Updated on ClinicalTrials.gov 2026-03-09